Drug class
5-nitroimidazole antiprotozoal and anaerobic antibacterial
Mechanism of action
The nitro group is reduced in susceptible anaerobic organisms and protozoa to reactive intermediates that damage DNA and inhibit nucleic-acid synthesis.
General use cases
- Treatment of susceptible protozoal infections such as amoebiasis, giardiasis and trichomoniasis in countries where authorised
- Treatment of selected anaerobic bacterial infections; indications and regimens depend on local product authorisation
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
